UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 29, 2023
Accession Number:
0001104659-23-121793
Submission Type:
POS AM
CIK:
0001574232
Company Name:
Addex Therapeutics Ltd.
File Number:
333-271611